Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: An exploratory study of relationships with abstinence during behavioral treatment1

Drug and Alcohol Dependence

Volumn 140, Issue , 2014, Pages 33-41

  Yip, Sarah W ^a   DeVito, Elise E ^a   Kober, Hedy ^a   Worhunsky, Patrick D ^a   Carroll, Kathleen M ^a   Potenza, Marc N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis dependence; Cognitive behavioral therapy; Contingency management; FMRI; FSL FIRST; Reward processing

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; BEHAVIOR THERAPY; BRAIN FUNCTION; CANNABIS ADDICTION; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; REWARD; SEXUAL BEHAVIOR; SKILL; TREATMENT OUTCOME; TREATMENT RESPONSE; VERBAL MEMORY; VISUAL MEMORY; BRAIN; MARIJUANA ABUSE; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

CANNABIS;

ADULT; BRAIN; COGNITIVE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84924843155     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.03.031     Document Type: Article

References (73)

1. Andrade L.F., Carroll K.M., Petry N.M. Marijuana use is associated with risky sexual behaviors in treatment-seeking polysubstance abusers. Am. J. Drug Alcohol Abuse 2013, 39:266-271.
2. Andrews M.M., Meda S.A., Thomas A.D., Potenza M.N., Krystal J.H., Worhunsky P., Stevens M.C., O'Malley S., Book G.A., Reynolds B., Pearlson G.D. Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol. Psychiatry 2011, 69:675-683.
3. Balodis I.M., Kober H., Worhunsky P.D., Stevens M.C., Pearlson G.D., Potenza M.N. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol. Psychiatry 2012, 71:749-757.
4. Batalla A., Bhattacharyya S., Yücel M., Fusar-Poli P., Crippa J.A., Nogué S., Torrens M., Pujol J., Farré M., Martin-Santos R. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One 2013, 8:e55821.
5. Beck A., Schlagenhauf F., Wustenberg T., Hein J., Kienast T., Kahnt T., Schmack K., Hagele C., Knutson B., Heinz A., Wrase J. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol. Psychiatry 2009, 66:734-742.
6. Bolla K.L., Brown K., Eldreth D.A., Tate K., Cadet J.L. Dose-related neurocognitive effects of marijuana use. Neurolology 2002, 59:1337-1343.
7. Bora E., Yucel M., Allen N.B. Neurobiology of human affiliative behaviour: implications for psychiatric disorders. Curr. Opin. Psychiatry 2009, 22:320-325.
8. Bossong M.G., van Berckel B.N.M., Boellaard R., Zuurman L., Schuit R.C., Windhorst A.D., van Gerven J.M.A., Ramsey N.F., Lammertsma A.A., Kahn R.S. [Delta]9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2008, 34:759-766.
9. Brewer J.A., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Potenza M.N. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol. Psychiatry 2008, 64:998-1004.
10. Brody A.L., Mandelkern M.A., Jarvik M.E., Lee G.S., Smith E.C., Huang J.C., Bota R.G., Bartzokis G., London E.D. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol. Psychiatry 2004, 55:77-84.
11. Carroll K.M., Easton C.J., Nich C., Hunkele K.A., Neavins T.M., Sinha R., Ford H.L., Vitolo S.A., Doebrick C.A., Rounsaville B.J. The use of contingency management and motivation/skills building therapy to treat young adults with marijuana dependence. J. Consult. Clin. Psychol. 2006, 74:955-966.
12. Carroll K.M., Kiluk B.D., Nich C., DeVito E.E., Decker S., LaPaglia D., Duffey D., Babuscio T.A., Ball S.A. Toward empirical identification of a clinically meaningful indicator of treatment outcome: Features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine useoutcomes. Drug Alcohol Depend 2014, 137:3-19.
13. Carroll K.M., Nich C., LaPaglia D.M., Peters E.N., Easton C.J., Petry N.M. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction 2012, 107:1650-1659.
14. Chang L., Alicata D., Ernst T., Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102:16-32.
15. Chung T., Pajtek S., Clark D.B. White matter integrity as a link in the association between motivation to abstain and treatment outcome in adolescent substance users. Psychol. Addict. Behav. 2013, 27:533-542.
16. Cousijn J., Goudriaan A.E., Ridderinkhof K.R., van den Brink W., Veltman D.J., Wiers R.W. Neural responses associated with cue-reactivity in frequent cannabis users. Addict. Biol. 2013, 18:570-580.
17. Crunelle C.L., Schulz S., de Bruin K., Miller M.L., van den Brink W., Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. Eur. Neuropsychopharmacol. 2011, 21:205-210.
18. Danovitch I., Gorelick D.A. State of the art treatments for cannabis dependence. Psychiatr. Clin. North Am. 2012, 35:309-326.
19. Degenhardt L., Coffey C., Romaniuk H., Swift W., Carlin J.B., Hall W.D., Patton G.C. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013, 108:124-133.
20. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379:55-70.
21. Degenhardt L., Hall W.D., Lynskey M., McGrath J., McLaren J., Calabria B., Whiteford H., Vos T. Should burden of disease estimates include cannabis use as a risk factor for psychosis?. PLoS Med. 2009, 6:e1000133.
22. Denis C., Lavie E., Fatseas M., Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. Cochrane Database Syst. Rev. 2006, 9:CD005336.
23. Donovan D.M., Bigelow G.E., Brigham G.S., Carroll K.M., Cohen A.J., Gardin J.G., Hamilton J.A., Huestis M.A., Hughes J.R., Lindblad R., Marlatt G.A., Preston K.L., Selzer J.A., Somoza E.C., Wakim P.G., Wells E.A. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 2012, 107:694-708.
24. Everitt B.J., Robbins T.W. From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 2013, 37:1946-1954.
25. Feldstein Ewing S.W., Chung T. Neuroimaging mechanisms of change in psychotherapy for addictive behaviors: emerging translational approaches that bridge biology and behavior. Psychol. Addict. Behav. 2013, 27:329-335.
26. Filbey F.M., Dunlop J., Myers U.S. Neural effects of positive and negative incentives during marijuana withdrawal. PLoS One 2013, 8:e61470.
27. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV 1995, American Psychiatric Press, Inc., Washington, DC. Patient Edition.
28. Forbes E., Olino T., Ryan N., Birmaher B., Axelson D., Moyles D., Dahl R. Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder. Cogn. Affect. Behav. Neurosci. 2010, 10:107-118.
29. Froeliger B., Kozink R.V., Rose J.E., Behm F.M., Salley A.N., McClernon F.J. Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. Psychopharmacology (Berlin) 2010, 210:577-583.
30. Froeliger B., Modlin L.A., Kozink R.V., Wang L., Garland E.L., Addicott M.A., McClernon F.J. Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. Psychiatry Res. 2013, 211:57-63.
31. Goldman M., Szucs-Reed R.P., Jagannathan K., Ehrman R.N., Wang Z., Li Y., Suh J.J., Kampman K., O'Brien C.P., Childress A.R., Franklin T.R. Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects. J. Addict. Med. 2013, 7:8-16.
32. Goldstein R.Z., Alia-Klein N., Tomasi D., Zhang L., Cottone L.A., Maloney T., Telang F., Caparelli E.C., Chang L., Ernst T., Samaras D., Squires N.K., Volkow N.D. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?. Am. J. Psychiatry 2007, 164:43-51.
33. Gruber S.A., Sagar K.A., Dahlgren M.K., Racine M., Lukas S.E. Age of onset of marijuana use and executive function. Psychol. Addict. Behav. 2012, 26:496-506.
34. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374:1383-1391.
35. Jager G., Block R.I., Luijten M., Ramsey N.F. Tentative evidence for striatal hyperactivity in adolescent cannabis-using boys: a cross-sectional multicenter fMRI study. J. Psychoactive Drugs 2013, 45:156-167.
36. Jia Z., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Stevens M.C., Pearlson G.D., Potenza M.N. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol. Psychiatry 2011, 70:553-560.
37. Kadden R.M., Litt M.D., Kabela-Cormier E., Petry N.M. Abstinence rates following behavioral treatments for marijuana dependence. Addict. Behav. 2007, 32:1220-1236.
38. Kim S.J., Lyoo I.K., Hwang J., Chung A., Hoon Sung Y., Kim J., Kwon D.-H., Chang K.H., Renshaw P.F. Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int. J. Neuropsychopharmacol. 2006, 9:221-228.
39. Kingree J.B., Betz H. Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug Alcohol Depend. 2003, 72:197-203.
40. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 2001, 21:151-155.
41. Knutson B., Fong G.W., Adams C.M., Varner J.L., Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 2001, 12:3683-3687.
42. Knutson B., Greer S.M. Anticipatory affect: neural correlates and consequences for choice. Philos. Trans. R. Soc. London, Ser. B 2008, 363:3771-3786.
43. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2009, 35:217-238.
44. Leroy C., Karila L., Martinot J.-L., Lukasiewicz M., Duchesnay E., Comtat C., Dollé F., Benyamina A., Artiges E., Ribeiro M.-J., Reynaud M., Trichard C. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict. Biol. 2012, 17:981-990.
45. Liu X., Hairston J., Schrier M., Fan J. Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci. Biobehav. Rev. 2011, 35:1219-1236.
46. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19:1233-1239.
47. Mathews R.R., Hall W.D., Gartner C.E. Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med. J. Aust. 2011, 195:S12-S15.
48. Meier M.H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R.S.E., McDonald K., Ward A., Poulton R., Moffitt T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:2657-2664.
49. Montague P.R., Hyman S.E., Cohen J.D. Computational roles for dopamine in behavioural control. Nature 2004, 431:760-767.
50. Moore T.H.M., Zammit S., Lingford-Hughes A., Barnes T.R.E., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
51. Nestor L., Hester R., Garavan H. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage 2010, 49:1133-1143.
52. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011, 56:907-922.
53. Peters E.N., Budney A.J., Carroll K.M. Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addict 2012, 107:1404-1417.
54. Peters J., Bromberg U., Schneider S., Brassen S., Menz M., Banaschewski T., Conrod P.J., Flor H., Gallinat J., Garavan H., Heinz A., Itterman B., Lathrop M., Martinot J.-L., Paus T., Poline J.-B., Robbins T.W., Rietschel M., Smolka M., Ströhle A., Struve M., Loth E., Schumann G., Büchel C. Lower ventral striatal activation during reward anticipation in adolescent smokers. Am. J. Psychiatry 2011, 168:540-549.
55. Pierce R.C., Vanderschuren L.J.M.J. Kicking the habit: the neural basis of ingrained behaviors in cocaine addiction. Neurosci. Biobehav. Rev. 2010, 35:212-219.
56. Potenza M. How central is dopamine to pathological gambling or gambling disorder?. Front. Behav. Neurosci. 2013, 10.3389/fnbeh.2013.00206.
57. Potenza, Marc N., Sofuoglu M., Carroll Kathleen M., Rounsaville Bruce J. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 2011, 69:695-712.
58. Rogers R.D., Robbins T.W. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr. Opin. Neurobiol. 2001, 11:250-257.
59. Roitman M.F., Wheeler R.A., Carelli R.M. Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron 2005, 45:587-597.
60. Schlageter N.L., Horwitz B., Creasey H., Carson R., Duara R., Berg G.W., Rapoport S.I. Relation of measured brain glucose utilisation and cerebral atrophy in man. J. Neurol. Neurosurg. Psychiatry 1987, 50:779-785.
61. Schönberg T., Daw N.D., Joel D., O'Doherty J.P. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J. Neurosci. 2007, 27:12860-12867.
62. Sevy S., Smith G., Ma Y., Dhawan V., Chaly T., Kingsley P., Kumra S., Abdelmessih S., Eidelberg D. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacol 2008, 197:549-556.
63. Stinson F.S., Ruan W.J., Pickering R., Grant B.F. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol. Med. 2006, 36:1447-1460.
64. Thayer R.E., Hutchison K.E. Neuroimaging in clinical studies of craving: importance of reward and control networks. Psychol. Addict. Behav 2013, 27:543-546.
65. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
66. van Hell H.H., Vink M., Ossewaarde L., Jager G., Kahn R.S., Ramsey N.F. Chronic effects of cannabis use on the human reward system: an fMRI study. Eur. Neuropsychopharmacol. 2010, 20:153-163.
67. van Holst R.J., Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr. Drug Abuse Rev. 2011, 4:42-56.
68. van Wingen G.A., van den Brink W., Veltman D.J., Schmaal L., Dom G., Booij J., Crunelle C.L. Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug Alcohol Depend. 2013, 131:198-203.
69. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(1):3-8.
70. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.L., Dewey S.L., Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14:169-177.
71. Wrase J., Schlagenhauf F., Kienast T., Wustenberg T., Bermpohl F., Kahnt T., Beck A., Strohle A., Juckel G., Knutson B., Heinz A. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 2007, 35:787-794.
72. Xu J., DeVito E.E., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Potenza M.N. White matter integrity is associated with treatment outcome measures in cocaine dependence. Neuropsychopharmacology 2010, 35:1541-1549.
73. Yin H.H., Knowlton B.J., Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 2004, 19:181-189.